Preci’s DMPK product suite is engineered to support rigorous drug metabolism and pharmacokinetic (DMPK) analysis, utilizing high-quality human hepatocytes, human liver microsomes, and other subcellular fractions. Designed for precision and reproducibility, our human-derived cellular assays, including hepatocyte and microsomal assays, are sourced from an extensive clinical network and undergo stringent quality control to ensure batch-to-batch consistency. With single-donor and pooled hepatocyte batches reserved for long-term use, our DMPK products provide unparalleled reliability for studies focused on metabolic clearance, toxicity, and drug-drug interactions. Partnering with Preci grants researchers access to specialized reagents and consumables optimized for complex DMPK workflows, simplifying experimental processes while supporting comprehensive and reproducible results.